Lesley Ann Saketkoo,Reuben Escorpizo,Janos Varga,Kevin John Keen,Kim Fligelstone,Surinder S Birring,Helene Alexanderson,Henrik Pettersson,Humza Ahmad Chaudhry,Janet L Poole,Malin Regardt,Daphne LeSage,Catherine Sarver,Joseph Lanario,Elisabetta Renzoni,Mary Beth Scholand,Matthew R Lammi,Otylia Kowal-Bielecka,Oliver Distler,Tracy Frech,Lee Shapiro,Cecilia Varju,Elizabeth R Volkmann,Elana J Bernstein,Marjolein Drent,Ogugua Ndili Obi,Karen C Patterson,Anne-Marie Russell,Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS)

Abstract:Background: The World Health Organization (WHO) introduced the International Classification of Functioning, Disability, and Health (ICF) as a scientific method of disability data collection comprised of >1,200 categories describing the spectrum of impairment types (functional, symptoms-based and anatomical) under the bio-psycho-social model with consideration of environmental and personal factors (pf). ICF Core Sets and ICF Checklists are streamlined disease-specific resources for clinical use, service provision, and for use in health economics and health policy. ICF can disclose strengths and weaknesses across multiple patient-reported outcome measures (PROMs) and help consolidate best-fitting question-items from multiple PROMs. Interstitial lung diseases (ILDs), are generally progressive, with restrictive physiology sometimes occurring in the context of multi-organ autoimmunity/inflammatory conditions such as connective tissue diseases (CTDs). In spite of significant associated morbidity and potential disability, ILD has yet to be linked to the ICF. Methods: Each instrument and their question-items within the consensus-recommended core sets for clinical trials in ILD were deconstructed to single concept units, and then linked per updated ICF linkage rules. Inter-linker agreement was established. Three additional subsequently validated measures were also included. Results: One-hundred-eleven ICF categories were identified for ten PROMs and three traditional objective measures that were amenable to ICF linkage. The proportion of agreement ranged from 0.79 (95% CI: 0.62, 0.91) to 0.93 (0.76, 0.99) with the overall proportion of inter-linker agreement being very high 0.86 (0.82, 0.89) for the initial instruments, with 94-100% for the three additional PROMs. Thirty-four new 'Personal Factors' emerged to capture disease-specific qualities not elsewhere described in ICF, e.g. 'pf_embarrassed by cough' or 'pf_panic/afraid when can't get a breath'. Conclusion: This first known effort in ICF linkage of ILD has provided important revelations on the current utility of the ICF in lung disease. Results have indicated areas for meaningful assessment of ICF descriptors for lung impairment. The mapping across PROMs provides insight into possibilities of developing more streamline and precise instrumentation. Finally, familiarity with the ICF in ILD may enable clinicians to experience a smoother transition with the imminent harmonization of ICD and ICF, ICD-11.

Development and initial validation of the ILD-Anxiety-Questionnaire (IAQ): A new instrument for assessing disease specific fears in interstitial lung disease

Development And Validation Of A Questionnaire To Assess The Quality Of Life In Patients With Inflammatory Bowel Disease In Mainland China

Development and evaluation of a questionnaire to capture environmental and occupational inhalational exposures in adults with fibrotic interstitial lung disease

Assessment of health-related quality of life in individuals with interstitial lung diseases in a tertiary care hospital in south India

World Health Organization (WHO) International Classification of Functioning, Disability and Health (ICF) Core Set Development for Interstitial Lung Disease

Assessing health-related quality of life in patients with interstitial lung diseases

Nutritional status and quality of life in interstitial lung disease: a prospective cohort study

P291 Longitudinal assessment of Illness Identity in patients with Inflammatory Bowel Disease

Health‐related quality scores in childhood interstitial lung disease: Good agreement between patient and caregiver reports

Assessment of quality of life in IPF Patients: a multicenter observational study

Influence of pulmonary rehabilitation on symptoms of anxiety and depression in interstitial lung disease: A systematic review of randomized controlled trials

Knowledge, attitude, and practice toward interstitial lung disease among patients: a cross-sectional study

Cross-sectional and Longitudinal Construct Validity of the Saint George's Respiratory Questionnaire in Patients with IPF.

The Interoceptive Sensitivity and Attention Questionnaire: Evaluating Aspects of Self-Reported Interoception in Patients With Persistent Somatic Symptoms, Stress-Related Syndromes, and Healthy Controls

Relationship between high-resolution computed tomography quantitative imaging analysis and physiological and clinical features in antisynthetase syndrome-related interstitial lung disease

Protocol and research program of the European registry and biobank for interstitial lung diseases (eurILDreg)

Development and validation of a rapid, generic measure of disease control from the patient's perspective: the IBD-control questionnaire

Evaluating Sensitization-Associated, Neuropathic-Like Symptoms and Psychological Factors in Patients with Interstitial Lung Disease

Development and validation of quality of life instrument for patients with irritable bowel syndrome

Impact of pain, fatigue and bowel incontinence on the quality of life of people living with inflammatory bowel disease: A UK cross-sectional survey

The development of a cryptoglandular anal fistula quality of life scale (AF‐QoL)